Clinical Applications of Dynamic Susceptibility Contrast Perfusion-weighted MR Imaging in Brain Tumours

Overview

Journal Radiol Med

Specialty Radiology

Date 2011 Sep 6

PMID 21892719

Citations 14

Authors

A Romano

M C Rossi Espagnet

L F Calabria

V Coppola

L Figa Talamanca

V Cipriani

G Minniti

A Pierallini

L M Fantozzi

A Bozzao

Affiliations

Soon will be listed here.

Abstract

Magnetic resonance imaging (MRI) with a dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI) sequence to study brain tumours provides information on the haemodynamic characteristics of the neoplastic tissue. Brain perfusion maps and calculation of perfusion parameters, such as relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV) and mean transit time (MTT) allow assessment of vascularity and angiogenesis within tumours of the central nervous system (CNS), thus providing additional information to conventional MRI sequences. Although DSC-PWI has long been used, its clinical use in the study of brain tumours in daily clinical practice is still to be defined. The aim of this review was to analyse the application of perfusion MRI in the study of brain tumours by summarising our personal experience and the main results reported in the literature.

Citing Articles

From morphology to single-cell molecules: high-resolution 3D histology in biomedicine.

Xu X, Su J, Zhu R, Li K, Zhao X, Fan J Mol Cancer. 2025; 24(1):63.

PMID: 40033282 PMC: 11874780. DOI: 10.1186/s12943-025-02240-x.

Comparison of Arterial Spin-Labeling and DSC Perfusion MR Imaging in Pediatric Brain Tumors: A Systematic Review and Meta-Analysis.

Vella S, Lauri J, Grech R AJNR Am J Neuroradiol. 2024; 46(1):178-185.

PMID: 39122472 PMC: 11735421. DOI: 10.3174/ajnr.A8442.

Pre-operative spinal cord perfusion quantified by DSC MRI as a predictor of post-operative prognosis in patients with cervical spondylotic myelopathy.

Song Q, Wang C, Jiang W, Wang J, Li J, Guo H Eur Spine J. 2024; 33(9):3602-3608.

PMID: 39048843 DOI: 10.1007/s00586-024-08417-0.

Probing the glioma microvasculature: a case series of the comparison between perfusion MRI and intraoperative high-frame-rate ultrafast Doppler ultrasound.

Alafandi A, Tbalvandany S, Arzanforoosh F, Van der Voort S, Incekara F, Verhoef L Eur Radiol Exp. 2024; 8(1):13.

PMID: 38273190 PMC: 10810769. DOI: 10.1186/s41747-023-00406-0.

Perfusion-Weighted Imaging: The Use of a Novel Perfusion Scoring Criteria to Improve the Assessment of Brain Tumor Recurrence versus Treatment Effects.

Sai Mannam S, Nwagwu C, Sumner C, Weinberg B, Hoang K Tomography. 2023; 9(3):1062-1070.

PMID: 37368539 PMC: 10302394. DOI: 10.3390/tomography9030087.

References

Caseiras G, Chheang S, Babb J, Rees J, Pecerrelli N, Tozer D . Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting. Eur J Radiol. 2009; 73(2):215-20. DOI: 10.1016/j.ejrad.2008.11.005. View

Cha S, Lupo J, Chen M, Lamborn K, McDermott M, Berger M . Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol. 2007; 28(6):1078-84. PMC: 8134129. DOI: 10.3174/ajnr.A0484. View

Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Bando E . Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol. 2010; 99(1):81-8. DOI: 10.1007/s11060-009-0106-z. View

Lev M, Ozsunar Y, Henson J, Rasheed A, Barest G, Harsh 4th G . Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol. 2004; 25(2):214-21. PMC: 7974605. View

Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T . Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol. 1998; 171(6):1479-86. DOI: 10.2214/ajr.171.6.9843274. View

Danchaivijitr N, Waldman A, Tozer D, Benton C, Brasil Caseiras G, Tofts P . Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?. Radiology. 2008; 247(1):170-8. DOI: 10.1148/radiol.2471062089. View

Lee I, Kim S, Kim H, Kim K, Jeon P, Byun H . Analysis of perfusion weighted image of CNS lymphoma. Eur J Radiol. 2009; 76(1):48-51. DOI: 10.1016/j.ejrad.2009.05.013. View

Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T . Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol. 2000; 21(5):901-9. PMC: 7976740. View

Barajas Jr R, Chang J, Segal M, Parsa A, McDermott M, Berger M . Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2009; 253(2):486-96. PMC: 2770116. DOI: 10.1148/radiol.2532090007. View

10.

Law M, Oh S, Johnson G, Babb J, Zagzag D, Golfinos J . Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery. 2006; 58(6):1099-107. DOI: 10.1227/01.NEU.0000215944.81730.18. View

11.

Lupo J, Cha S, Chang S, Nelson S . Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol. 2005; 26(6):1446-54. PMC: 8149056. View

12.

Hakyemez B, Erdogan C, Gokalp G, Dusak A, Parlak M . Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI. Clin Radiol. 2010; 65(1):15-20. DOI: 10.1016/j.crad.2009.09.005. View

13.

Maia Jr A, Malheiros S, da Rocha A, da Silva C, Gabbai A, Ferraz F . MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol. 2005; 26(4):777-83. PMC: 7977110. View

14.

Bulakbasi N, Kocaoglu M, Farzaliyev A, Tayfun C, Ucoz T, Somuncu I . Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol. 2005; 26(9):2187-99. PMC: 7976133. View

15.

Kremer S, Grand S, Remy C, Pasquier B, Benabid A, Bracard S . Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology. 2004; 46(8):642-8. DOI: 10.1007/s00234-004-1194-2. View

16.

Cha S, Tihan T, Crawford F, Fischbein N, Chang S, Bollen A . Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2005; 26(2):266-73. PMC: 7974081. View

17.

Hirai T, Murakami R, Nakamura H, Kitajima M, Fukuoka H, Sasao A . Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study. AJNR Am J Neuroradiol. 2008; 29(8):1505-10. PMC: 8119049. DOI: 10.3174/ajnr.A1121. View

18.

Cha S, Knopp E, Johnson G, Wetzel S, Litt A, Zagzag D . Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002; 223(1):11-29. DOI: 10.1148/radiol.2231010594. View

19.

Henry R, Vigneron D, Fischbein N, Grant P, Day M, Noworolski S . Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol. 2000; 21(2):357-66. PMC: 7975338. View

20.

Aronen H, Gazit I, Louis D, Buchbinder B, Pardo F, Weisskoff R . Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 1994; 191(1):41-51. DOI: 10.1148/radiology.191.1.8134596. View